Clinical Trials Logo

Filter by:
NCT ID: NCT00130949 Completed - Tennis Elbow Clinical Trials

ALGRX 4975 in the Treatment of Tennis Elbow

Start date: November 2004
Phase: Phase 2
Study type: Interventional

Tennis elbow is a painful condition that results from repetitive arm movement with overuse of muscles, e.g. when playing tennis. A single injection of ALGRX 4975 has the potential to reduce pain for a period of weeks to months. This study will test the efficacy and safety of ALGRX 4975 in the treatment of patients with tennis elbow.

NCT ID: NCT00128531 Completed - Prostate Cancer Clinical Trials

Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

Start date: September 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to look at the efficacy and safety of leuprolide acetate in patients with prostate cancer.

NCT ID: NCT00126022 Completed - Atrial Fibrillation Clinical Trials

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

Start date: December 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the ability of tedisamil to convert atrial fibrillation or flutter into normal sinus rhythm (NSR) in female patients.

NCT ID: NCT00126009 Completed - Bipolar Disorder Clinical Trials

SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients

Start date: May 2004
Phase: Phase 2
Study type: Interventional

The primary objective is: - To compare the efficacy of the association valproate-amisulpride (400 to 800 mg/day) to the association valproate-haloperidol (5 to 15 mg/day) in bipolar I patients suffering from a manic episode according to DSM IV TR (American Psychiatric Association [APA] 2000) and treated for a 3-month period. The secondary objectives are: - To evaluate the clinical and biological safety of the association valproate-amisulpride to the association valproate-haloperidol; - To assess the patient status 3 weeks and 3 months after inclusion; and - To assess patient satisfaction at 3 months.

NCT ID: NCT00122460 Completed - Clinical trials for Head and Neck Cancer

Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)

Start date: December 2004
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to investigate the efficacy of cetuximab in combination with chemotherapy in comparison to chemotherapy alone in patients with recurrent or metastatic head and neck cancer. Overall survival will be taken as the primary measure of efficacy.

NCT ID: NCT00111644 Completed - Clinical trials for Pneumonia, Bacterial

A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia

Start date: March 2005
Phase: Phase 2
Study type: Interventional

This study will assess the efficacy and safety of intravenous beta-lactam, in comparison with ceftriaxone, in hospitalized patients with community-acquired pneumonia not caused by Legionella. The anticipated time on study treatment is 3-12 months and the target sample size is 100-500 individuals.

NCT ID: NCT00110045 Completed - Cancer Clinical Trials

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Start date: February 2005
Phase: Phase 2
Study type: Interventional

RATIONALE: Antifungals, such as caspofungin acetate, may be effective in treating fungal infections caused by chemotherapy or stem cell transplant. PURPOSE: This phase II trial is studying how well caspofungin acetate works as first-line treatment for aspergillosis in patients with hematologic cancer or in patients who have undergone a stem cell transplant.

NCT ID: NCT00108914 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Perennial Allergic Rhinitis Study In Pediatric Subjects

Start date: February 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the investigational drug is effective and safe in children with perennial allergic rhinitis.

NCT ID: NCT00107926 Completed - Bipolar Disorder Clinical Trials

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and tolerability of an investigational drug for the treatment of manic episodes of bipolar disorder. The investigational drug will be given as additional treatment with either lithium or valproate, which are already FDA (Food and Drug Administration)-approved treatments for mania.

NCT ID: NCT00106548 Completed - Clinical trials for Rheumatoid Arthritis

A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Start date: n/a
Phase: Phase 3
Study type: Interventional

This 3 arm study will compare the safety and efficacy, with regard to reduction of signs and symptoms, of tocilizumab versus placebo, both in combination with methotrexate (MTX). in patients with moderate to severe active rheumatoid arthritis (RA) who currently have an inadequate response to MTX. Patients wil be randomized to receive tocilizumab 4mg/kg iv, tocilizumab 8mg/mg iv, or placebo iv, every 4 weeks; all patients will also receive methotrexate 10-25mg weekly. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.